Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Applied DNA Sciences Inc (APDN) had Stock-Based Compensation of $0.57M for the most recently reported fiscal year, ending 2024-09-30.
| Income Statement Financials | |
$3.43M |
|
$-7.23M |
|
$2.41M |
|
$1.02M |
|
$17.46M |
|
$-14.02M |
|
$6.94M |
|
$-7.09M |
|
$-7.09M |
|
$-7.09M |
|
$-7.09M |
|
$-7.09M |
|
$-7.09M |
|
$-14.02M |
|
$-13.33M |
|
0.01M |
|
0.01M |
|
$-1364.32 |
|
$-1364.32 |
|
| Balance Sheet Financials | |
$8.05M |
|
$0.55M |
|
$4.74M |
|
$12.79M |
|
$2.40M |
|
-- |
|
$1.42M |
|
$3.82M |
|
$8.97M |
|
$6.27M |
|
$8.97M |
|
0.01M |
|
| Cash Flow Statement Financials | |
$-13.71M |
|
$-0.41M |
|
$13.40M |
|
$7.90M |
|
$7.18M |
|
$-0.72M |
|
|
Stock-Based Compensation |
$0.57M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
29.63% |
|
-408.72% |
|
-408.72% |
|
-388.42% |
|
-206.57% |
|
-210.57% |
|
$-14.12M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
5.51 |
|
9.48 |
|
38.51 |
|
-79.04% |
|
-113.07% |
|
-55.42% |
|
-79.04% |
|
$651.94 |
|
$-2668.71 |
|
$-2591.61 |
|